Does timolol LA enhance the disrupting effect of travoprost on the blood-aqueous barrier?
Vishwanath
Mandagere R
MR
Charles
Stephen J
SJ
D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D018916:Blood-Aqueous Barrier / Q000187:drug effects*; D003008:Cloprostenol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006068:Gonioscopy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D009798:Ocular Hypertension / Q000188:drug therapy*; D013999:Timolol / Q000627:therapeutic use*; D000069557:Travoprost; D014606:Uveitis, Anterior / Q000139:chemically induced
D000959:Antihypertensive Agents; D003008:Cloprostenol; D013999:Timolol; D000069557:Travoprost